
Yuri Deigin - Partial Reprogramming Drug Development for Aging
The Bioinformatics CRO Podcast
00:00
Is Reprogramming Really a Therapy for Aging?
I think reprogramming is like if we're talking in the context of partial reprogramming, I think it has a whole host of different areas in which you could demonstrate benefits. Depending on the actual intervention, they could have different optimal targets, optimal diseases that could be the first ones to go after in a clinical setting. In the context of skin, as people think, is a low-hane fruit because you can have very quick results and visually observable improvements. And also other areas in terms of hematology and immunology people are also considering. So while they're very neurodegenerative diseases, they're obviously hard nuts to crack. The upside in their cases is really
Play episode from 10:14
Transcript


